Enzo Biochem, Inc.
Enzo Biochem is a leading life
sciences and biotechnology company focused on harnessing
genetic processes to develop research tools, diagnostics
and therapeutics and provides reference laboratory
services to the medical community. Founded in 1976, we
have concentrated on the development of enabling
technologies in the areas of gene regulation and gene
modification. Many of our technologies are applicable to
the biomedical and pharmaceutical research markets, and
we are further using these technologies as a platform
for our entry into the clinical diagnostics market.
Today, Enzo technologies and products are recognized as
the key tools in non-radioactive gene labeling used by
researchers worldwide. Additionally, Enzo's work in gene
analysis has led to development of a number of
significant therapeutic candidates for the treatment of
viral and immunological based disorders, several of
which are in various phases of human clinical trials. In
the course of our extensive research and development
activities, we have built a significant patent position
consisting of numerous pioneer patents and applications
that encompass our core technologies.
business activities of Enzo Biochem are performed by the
company's three wholly owned subsidiaries . . . Enzo
Life Sciences, Enzo Therapeutics and Enzo Clinical Labs.
Such activities include research and development,
manufacturing and marketing of biomedical research
products and tools through Enzo Life Sciences and
research and development of therapeutic products through
Enzo Therapeutics and the operation of a regional
clinical reference laboratory through Enzo Clinical
Enzo's vision of the importance of
recombinant DNA technology as an informational source
more than two decades ago has now become a major
direction in modern medicine.